Removing Race-Based Kidney Function Adjustment May Be Damaging for Black Cancer Patients
Written by Black Hot Fire Network on August 17, 2021
Research led by the University of Pittsburgh shows not accounting for race when calculating kidney function before starting anticancer treatments could lead to Black patients being unnecessarily excluded.
The team, led by Thomas Nolin, associate professor of pharmacy and therapeutics at Pitt’s School of Pharmacy, carried out the assessment because the necessity of the addition of race into the Chronic Kidney Disease-Epidemiology Collaboration (CKD-EPI) equation to calculate function has been recently called into question.
Estimated glomerular filtration rate (eGFR), a measure of kidney function, is known to vary to different degrees depending . . .
